- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 14
- Scientists listed
- 0
- Grants since 2016
- 4
Grants received
2020–2022 · research · R41
Targeted Therapies for the Treatment of GI-ARS Diarrhea
Gabor J Tigyi · RxBio (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.
(Contact) · RxBio (United States) · funded by National Institutes of Health
2018–2021 · contract · N01
IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.
Shannon Mccool · RxBio (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.
Shannon Mccool · RxBio (United States) · funded by National Institutes of Health
